These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 34011606)
1. DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions. Sato K; Yamashita-Kanemaru Y; Abe F; Murata R; Nakamura-Shinya Y; Kanemaru K; Muratani M; Veillette A; Goto M; Ito M; Shibuya A; Shibuya K Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011606 [TBL] [Abstract][Full Text] [Related]
2. DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses. Shibuya A; Shibuya K Int Immunol; 2021 Nov; 33(12):687-692. PubMed ID: 34694361 [TBL] [Abstract][Full Text] [Related]
3. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226. Fuhrman CA; Yeh WI; Seay HR; Saikumar Lakshmi P; Chopra G; Zhang L; Perry DJ; McClymont SA; Yadav M; Lopez MC; Baker HV; Zhang Y; Li Y; Whitley M; von Schack D; Atkinson MA; Bluestone JA; Brusko TM J Immunol; 2015 Jul; 195(1):145-55. PubMed ID: 25994968 [TBL] [Abstract][Full Text] [Related]
4. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions. Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457 [TBL] [Abstract][Full Text] [Related]
5. Characteristic of TIGIT and DNAM-1 Expression on Foxp3+ Jin Z; Ye W; Lan T; Zhao Y; Liu X; Chen J; Lai J; Chen S; Zhong X; Wu X Biomed Res Int; 2020; 2020():4612952. PubMed ID: 32802845 [TBL] [Abstract][Full Text] [Related]
6. The TIGIT/CD226 axis regulates human T cell function. Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644 [TBL] [Abstract][Full Text] [Related]
7. Promoting regulation via the inhibition of DNAM-1 after transplantation. Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Leveque L; Chan CJ; Robb RJ; Markey KA; Alexander KA; Varelias A; Clouston AD; Smyth MJ; MacDonald KP; Hill GR Blood; 2013 Apr; 121(17):3511-20. PubMed ID: 23430112 [TBL] [Abstract][Full Text] [Related]
8. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity. Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205 [TBL] [Abstract][Full Text] [Related]
9. Helios but not CD226, TIGIT and Foxp3 is a Potential Marker for CD4 Yang M; Liu Y; Mo B; Xue Y; Ye C; Jiang Y; Bi X; Liu M; Wu Y; Wang J; Olsen N; Pan Y; Zheng SG Cell Physiol Biochem; 2019; 52(5):1178-1192. PubMed ID: 30990587 [TBL] [Abstract][Full Text] [Related]
10. Essential role of CD155 glycosylation in functional binding to DNAM-1 on natural killer cells. Tahara S; Okumura G; Matsuo T; Shibuya A; Shibuya K Int Immunol; 2024 Apr; 36(6):317-325. PubMed ID: 38289706 [TBL] [Abstract][Full Text] [Related]
11. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells. Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041 [TBL] [Abstract][Full Text] [Related]
13. CD155 mutation (Ala67Thr) increases the binding affinity for and the signaling via an inhibitory immunoreceptor TIGIT. Matsuo T; Iguchi-Manaka A; Shibuya A; Shibuya K Cancer Sci; 2022 Nov; 113(11):4001-4004. PubMed ID: 35947095 [TBL] [Abstract][Full Text] [Related]
14. Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells. Bin Dhuban K; d'Hennezel E; Nashi E; Bar-Or A; Rieder S; Shevach EM; Nagata S; Piccirillo CA J Immunol; 2015 Apr; 194(8):3687-96. PubMed ID: 25762785 [TBL] [Abstract][Full Text] [Related]
15. Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity. DiToro D; Harbour SN; Bando JK; Benavides G; Witte S; Laufer VA; Moseley C; Singer JR; Frey B; Turner H; Bruning J; Darley-Usmar V; Gao M; Conover C; Hatton RD; Frank S; Colonna M; Weaver CT Immunity; 2020 Apr; 52(4):650-667.e10. PubMed ID: 32294406 [TBL] [Abstract][Full Text] [Related]
16. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice. Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663 [TBL] [Abstract][Full Text] [Related]
17. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT. Gilbert RM; Zhang X; Sampson RD; Ehrenstein MR; Nguyen DX; Chaudhry M; Mein C; Mahmud N; Galatowicz G; Tomkins-Netzer O; Calder VL; Lightman S Front Immunol; 2018; 9():907. PubMed ID: 29774027 [TBL] [Abstract][Full Text] [Related]
18. Mouse Double Minute 2 Homolog-Mediated Ubiquitination Facilitates Forkhead Box P3 Stability and Positively Modulates Human Regulatory T Cell Function. Wang A; Yang M; Liang R; Zhu F; Zhu F; Liu X; Han Y; Lin R; Wang X; Li D; Li H; Yuan X; Zhao H; Li B Front Immunol; 2020; 11():1087. PubMed ID: 32636834 [TBL] [Abstract][Full Text] [Related]
19. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. Du X; Shi H; Li J; Dong Y; Liang J; Ye J; Kong S; Zhang S; Zhong T; Yuan Z; Xu T; Zhuang Y; Zheng B; Geng JG; Tao W J Immunol; 2014 Feb; 192(4):1525-35. PubMed ID: 24453252 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of canonical NF-κB signaling maintains function and stability of human Treg. Ziegler LS; Gerner MC; Schmidt RLJ; Trapin D; Steinberger P; Pickl WF; Sillaber C; Egger G; Schwarzinger I; Schmetterer KG FEBS J; 2021 Jan; 288(2):640-662. PubMed ID: 32386462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]